Based on EAE pathogenesis, MS was initially considered driven by CD4 + T cells, mainly Th1 and Th17, according to the well-established involvement of HLA class II haplotypes in MS susceptibility [65]. This evidence concerns the gene CD4 and myeloid sarcoma.